Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -157.89% is 63% below its 5-year average of -97.13%, near the low end of its 5-year range (-157.89%–-70.01%).
77.39% below its 12-month average of -89.00%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -36.65%.
RETURN ON ASSETS (ROA)
-157.89%
RETURN ON ASSETS (ROA) AVG TTM
-89.00%
RETURN ON ASSETS (ROA) AVG 3Y
-102.14%
RETURN ON ASSETS (ROA) AVG 5Y
-97.13%
RETURN ON ASSETS (ROA) AVG 10Y
-74.79%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-77.39%
CURRENT VS 3Y AVG
-54.57%
CURRENT VS 5Y AVG
-62.56%
CURRENT VS 10Y AVG
-111.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.73%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
-413.88%
vs the sector median at left
ImmunityBio, Inc.
Market Cap
$10.41B
Return on Assets (ROA)
-157.89%
TTM Avg
-89.00%
3Y Avg
-102.14%
5Y Avg
-97.13%
Market Cap
$10.35B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$10.26B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.12B
Return on Assets (ROA)
1.41%
TTM Avg
0.38%
3Y Avg
2.34%
5Y Avg
2.99%
Market Cap
$10.10B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.75B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.02B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.01B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.98B
Return on Assets (ROA)
0.62%
TTM Avg
5.35%
3Y Avg
3.84%
5Y Avg
4.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.41B | -157.89% | -89.00% | -102.14% | -97.13% |
| Globus Medical, Inc. (GMED)vs › | $10.35B | 9.76% | 6.05% | 5.92% | 6.23% |
| Align Technology, Inc. (ALGN)vs › | $10.26B | 6.44% | 6.68% | 6.69% | 12.75% |
| Repligen Corporation (RGEN)vs › | $10.12B | 1.41% | 0.38% | 2.34% | 2.99% |
| The Ensign Group, Inc. (ENSG)vs › | $10.10B | 6.59% | 6.34% | 6.05% | 6.29% |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 9.58% | 8.61% | 6.84% | 6.99% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.02B | 2.17% | -6.26% | -11.14% | 1.46% |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | -0.04% | 5.29% | 6.08% | 6.13% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.98B | 0.62% | 5.35% | 3.84% | 4.82% |
| The Cooper Companies, Inc. (COO)vs › | $11.00B | 4.50% | 3.10% | 3.02% | 7.71% |
ROA
-157.9%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -70.01% |
| 2024-12-31 | -108.00% |
| 2023-12-31 | -115.61% |
| 2022-12-31 | -114.96% |
| 2021-12-31 | -73.96% |
| 2020-12-31 | -100.21% |
| 2019-12-31 | -45.97% |
| 2018-12-31 | -52.89% |
| 2017-12-31 | -38.50% |
| 2016-12-31 | -38.05% |
| 2015-12-31 | -64.57% |
| 2014-12-31 | -10.21% |
| 2013-12-31 | -97.34% |
